Skip to main content
Clinical Trials/NCT03131622
NCT03131622
Unknown
Not Applicable

Impact of Ibis, a Digital Health Solution for Patient Activation and Early Intervention, on Acute Care Utilization by Patients With Advanced COPD

Senscio Systems0 sites240 target enrollmentDecember 2016
ConditionsCOPD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD
Sponsor
Senscio Systems
Enrollment
240
Primary Endpoint
Reduction in Acute Care Utilization
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients with COPD.

Registry
clinicaltrials.gov
Start Date
December 2016
End Date
January 2018
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Gold Stage II with a CAT Score above 19
  • Gold Stage III/IV with a CAT Score above 14

Exclusion Criteria

  • Cognitive or physical impediments that inhibits patients from interacting with our digital therapeutics platform.

Outcomes

Primary Outcomes

Reduction in Acute Care Utilization

Time Frame: 6 months and then again at 1 year

Similar Trials